Ryan Haumschild, PharmD, MS, MBA, leads a discussion around the epidemiology of multiple sclerosis. Today, our panel of experts will explore the treatment landscape and impact of multiple sclerosis ...

DUBLIN--(BUSINESS WIRE)--The "Primary Progressive Multiple Sclerosis (PPMS) - An Overview" report has been added to Research and Markets' offering. The report provides an overview of primary ...

DUBLIN--(BUSINESS WIRE)--The "Secondary Progressive Multiple Sclerosis (SPMS) - Disease Overview and Epidemiology" report has been added to Research and Markets' offering. This report provides an ...

Peter L. Salgo, MD: Before we use a very broad brush, which we’ve been doing, to discuss multiple sclerosis [MS], we’ve been able to get the subgroups and subtypes, right? There are different kinds of ...

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...

Multiple sclerosis, or MS, is a central nervous system disorder that can cause progressively worse symptoms such as muscle weakness, blurred vision, and numbness. MS is typically diagnosed in a person ...

IFN-β and glatiramir acetate are the most widely used licensed disease-modifying treatments in MS. There is a consensus that they are acceptably safe and have partial efficacy, reducing the relapse ...

A great massage can help melt away stress and relax muscles. It may also ease certain multiple sclerosis (MS) symptoms. But it’s important to be aware of the pros and cons. You’ll also want to learn ...

The market for multiple sclerosis drugs is worth billions of dollars every year and these are the companies that benefit most. Multiple sclerosis, or MS, is a central nervous system disorder that can ...